Clinical Trials · NCT03070886
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
- Phase
- Phase 2/Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- NRG Oncology
- Enrollment
- 612
- Start date
- Apr 2017
- Locations
- 313 sites, 3 countries
- Primary endpoint
- Freedom from progression (FFP) (Phase II)